A 12-week feeding trial was conducted to evaluate the effects of dietary vitamin C on growth performance, antioxidant status and innate immune responses in juvenile yellow catfish, Pelteobagrus fulvidraco. Six isonitrogenous and isolipidic diets (44% crude protein and 7% lipid) were formulated to contain six graded dietary vitamin C (ascorbate-2-poly-phosphate, ROVIMIX â STAY-C â 35) levels ranging from 1.9 to 316.0 mg kg À1 diet. The results of present study indicated that fish fed the lowest vitamin C diet had lower weight gain (WG) and specific growth rate (SGR) than those fed the diets supplemented vitamin C. WG and SGR did significantly increase with dietary vitamin C levels increasing from 1.9 to 156.5 mg kg À1 . However, no significant increase was observed with further dietary vitamin C levels increasing from 156.5 to 316 mg kg À1 . Survival, protein efficiency ratio and feed efficiency were not significantly affected by the dietary vitamin C levels. The activities of serum superoxide dismutase, catalase and glutathione peroxidase significantly increased when dietary vitamin C levels increased from 1.9 to 156.5 mg kg À1 , fish fed the lowest vitamin C diet had higher serum malondialdehyde content than those fed the diets supplemented with vitamin C. Fish fed the diet containing 156.5 mg kg À1 vitamin C had the highest lysozyme, total complement activity, phagocytosis index and respiratory burst of head kidney among all treatments. The challenge test with Aeromonas hydrophila indicated that lower cumulative survival was observed in fish fed the lowest vitamin C diet. Analysis by broken-line regression of SGR and lysozyme activity indicated that the dietary vitamin C requirement of juvenile yellow catfish was estimated to be 114.5 and 102.5 mg kg À1 diet, respectively.

No abstract

No abstract

No abstract

No abstract

Surface-modified titanium dioxides by highly dispersed NiO particles have an extended absorption in the visible light region and a reduced hole-electron pair recombination than unmodified TiO2. They have now been successfully applied as highly active heterogeneous photocatalysts in the visible light mediated direct cyclization of tertiary anilines with maleimides to give tetrahydroquinoline products in moderate to high yields at ambient temperature. In contrast with unmodified titanium dioxide catalysts that are conventionally used in a stoichiometric amount in combination with UVA light, only a catalytic amount (1 mol %) of the surface-modified TiO2 catalyst is needed along with visible light to efficiently catalyze the reaction. Compared with transition-metal complexes such as Ru(bpy)3Cl2 or Ir(ppy)2(dtbbpy)PF6, advantages of these surface-modified titanium dioxides as photocatalyst include high catalytic activity, low cost, ease of recovering, and being able to be used for at least nine times without significant decay of catalytic activity.

No abstract

IMPORTANCEOwing to the good prognosis of differentiated thyroid cancer (DTC), guidelines recommend total thyroidectomy (TT) or thyroid lobectomy (TL) as surgical treatment for DTC with low to intermediate risk of recurrence. However, the association of these surgeries with the health-related quality of life (HRQOL) of patients with DTC with low to intermediate risk of recurrence is unclear.OBJECTIVE To longitudinally compare the HRQOL of patients with DTC undergoing different surgeries. DESIGN, SETTING, AND PARTICIPANTSThis prospective observational longitudinal cohort study enrolled patients diagnosed with DTC with low to intermediate risk of recurrence at the First Affiliated Hospital, Sun Yat-sen University, China, from October 1, 2018, to September 31, 2019. Eligible patients were categorized into TL and TT groups according to the surgery they underwent. They were evaluated preoperatively and followed up at 1, 3, 6, and 12 months postoperatively using 3 HRQOL-related questionnaires (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, version 3.0; Hospital Anxiety and Depression Scale; and Thyroid Cancer-Specific Quality of Life Questionnaire); serum thyrotropin levels, complications, and patient satisfaction were also monitored. Data were analyzed to compare the HRQOL of patients undergoing different surgeries at different time points.EXPOSURES Total thyroidectomy or TL. MAIN OUTCOMES AND MEASURESThe primary end point was HRQOL (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, version 3.0; Hospital Anxiety and Depression Scale; and Thyroid Cancer-Specific Quality of Life Questionnaire) at different time points, and the secondary end points were postoperative complications, thyrotropin level, and patient satisfaction. RESULTS Of the 1060 eligible patients, 563 underwent TL (438 women [77.8%]; median [IQR] age, 38 [31-45] years), and 497 underwent TT (390 women [78.5%]; median [IQR] age, 38 [32-48] years). Compared with the TL group, including the 1-to 4-cm tumor subgroup, the TT group experienced more postoperative HRQOL problems at 1 and 3 months postoperatively. However, nearly all the differences disappeared at 6 and 12 months postoperatively. CONCLUSIONS AND RELEVANCEResults of this study suggest that HRQOL of patients with DTC with low to intermediate risk of recurrence is not associated with the extent of surgery, and HRQOL may not be an important consideration when making surgical decisions. If better HRQOL is requested in the short term, TL may be preferred.